Euro Senior Unsecured Healthcare & Pharmaceuticals Corporate Bond Yields (EUR)
Fitted spot curve as of 2026-07-27
https://bondscovery.com/yield-curve/eur-corporate-senior-unsecured-healthcare-pharmaceuticals
Euro Senior Unsecured Healthcare & Pharmaceuticals Corporate Bond Yields (EUR) as of 2026-07-27: 10Y at 3.89%, fitted curve 1M–30Y (2.43%–4.94%), 94 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 1M | 2.43% | — |
| 3M | 2.54% | 2.59% |
| 6M | 2.68% | 2.83% |
| 12M | 2.89% | 3.10% |
| 18M | 3.02% | 3.28% |
| 2Y | 3.11% | 3.38% |
| 3Y | 3.24% | 3.51% |
| 4Y | 3.36% | 3.71% |
| 5Y | 3.47% | 3.91% |
| 6Y | 3.57% | 4.09% |
| 7Y | 3.67% | 4.23% |
| 8Y | 3.75% | 4.34% |
| 9Y | 3.83% | 4.42% |
| 10Y | 3.89% | 4.47% |
| 15Y | 4.14% | 4.64% |
| 20Y | 4.47% | 5.47% |
| 25Y | 4.75% | 5.87% |
| 30Y | 4.94% | 5.88% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 3.11% and the 10-year 3.89%, a 10Y−2Y spread of +78 bp — positively sloped — as of 2026-07-27. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-07-27 | 1m ago2026-06-26 | 2m ago2026-05-28 | 3m ago2026-04-28 | 4m ago2026-03-30 | 5m ago2026-02-27 | 6m ago2026-01-28 |
|---|---|---|---|---|---|---|---|
| 2Y | 3.11% | 2.93% | 3.03% | 2.99% | 3.20% | 2.55% | 2.59% |
| 10Y | 3.89% | 3.65% | 3.80% | 3.80% | 3.92% | 3.45% | 3.72% |
| 10Y − 2Y | +78 bp | +73 bp | +76 bp | +80 bp | +72 bp | +90 bp | +113 bp |
Yields by rating group
The same curve split by credit quality: 86 rated bonds across 3 rating bands, all maturities pooled. Median yield by band: AAA to AA- 3.19%, A+ to BBB- 3.71%, Speculative 4.34%.
Bonds in this curve
A selection of 30 of the 96 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Abbott Laboratories | 2.34% | 2026-09-27 | 1.50% | XS1883355197 |
| Fresenius SE & CO Kgaa | 2.87% | 2026-11-30 | 0.62% | XS2084497705 |
| Astrazeneca PLC | 2.96% | 2027-03-03 | 3.62% | XS2593105393 |
| Medtronic Global Holdings SCA | 2.59% | 2027-03-07 | 1.12% | XS1960678255 |
| Novo Nordisk Finance (Netherlands) B.V. | 2.86% | 2027-09-30 | 1.12% | XS2449330179 |
| Novartis | 2.48% | 2027-09-30 | 1.12% | XS1585010074 |
| Abbott Laboratories | 2.95% | 2027-11-19 | 0.38% | XS2076155105 |
| GSK Capital BV | 3.08% | 2027-11-28 | 3.00% | XS2553817680 |
| Astrazeneca PLC | 2.73% | 2028-05-12 | 1.25% | XS1411404426 |
| Novo Nordisk Finance (Netherlands) B.V. | 3.33% | 2028-05-27 | 2.38% | XS3002552993 |
| Sanofi SA | 2.91% | 2029-03-21 | 0.88% | FR0013409844 |
| Sanofi SA | 3.13% | 2029-04-06 | 1.25% | FR0014009KQ0 |
| Sanofi SA | 3.15% | 2030-03-21 | 1.38% | FR0013324357 |
| Sanofi SA | 3.19% | 2030-04-01 | 1.50% | FR0013505112 |
| Medtronic Global Holdings SCA | 3.43% | 2031-03-07 | 1.62% | XS1960678412 |
| Sanofi SA | 3.35% | 2031-03-11 | 2.75% | FR001400Y1I6 |
| Werfen SA/Spain | 3.99% | 2032-02-12 | 3.62% | XS3090952519 |
| Astrazeneca PLC | 3.47% | 2032-03-03 | 3.75% | XS2593105476 |
| Eurofins Scientific SE | 4.16% | 2033-02-05 | 3.88% | XS3135157298 |
| Novonesis A/S | 3.78% | 2033-03-19 | 3.62% | XS3320130175 |
| Danaher Corporation | 3.80% | 2034-04-29 | 3.62% | XS3352083409 |
| Fresenius SE & CO Kgaa | 4.05% | 2034-07-08 | 3.75% | XS3435670222 |
| Roche Holding AG | 3.57% | 2035-02-27 | 3.35% | XS2592088400 |
| Sandoz Finance B.V. | 4.04% | 2035-03-26 | 4.00% | XS3032013511 |
| GSK Capital BV | 3.85% | 2036-11-19 | 3.25% | XS2933692753 |
| Roche Holding AG | 3.75% | 2036-12-04 | 3.59% | XS2726335099 |
| Medtronic Global Holdings SCA | 4.09% | 2039-03-07 | 2.25% | XS1960678685 |
| Roche Holding AG | 4.14% | 2044-05-03 | 3.56% | XS2813211617 |
| Medtronic Global Holdings SCA | 4.61% | 2049-07-02 | 1.75% | XS2020671157 |
| BMS Ireland Capital Funding DAC | 4.92% | 2055-11-10 | 4.58% | XS3215466767 |